<SUBMISSION>
<ACCESSION-NUMBER>0001181431-10-004732
<TYPE>4
<PUBLIC-DOCUMENT-COUNT>1
<PERIOD>20100115
<FILING-DATE>20100126
<DATE-OF-FILING-DATE-CHANGE>20100126
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME>Wendel Bruce
<CIK>0001364846
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE>4
<ACT>34
<FILE-NUMBER>001-33657
<FILM-NUMBER>10548425
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1>2730 WILSHIRE BLVD., #500
<CITY>LOS ANGELES
<STATE>CA
<ZIP>90403
</MAIL-ADDRESS>
</REPORTING-OWNER>
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME>Abraxis BioScience, Inc.
<CIK>0001409012
<ASSIGNED-SIC>2834
<IRS-NUMBER>300431735
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1>11755 WILSHIRE BLVD., 20TH FLOOR
<CITY>LOS ANGELES
<STATE>CA
<ZIP>90025
<PHONE>310-883-1300
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>11755 WILSHIRE BLVD., 20TH FLOOR
<CITY>LOS ANGELES
<STATE>CA
<ZIP>90025
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Abraxis Biosciences, Inc.
<DATE-CHANGED>20071120
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>New Abraxis, Inc.
<DATE-CHANGED>20070806
</FORMER-COMPANY>
</ISSUER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd263589.xml
<DESCRIPTION>ABII FORM 4 WENDEL 20100115
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2010-01-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001409012</issuerCik>
        <issuerName>Abraxis BioScience, Inc.</issuerName>
        <issuerTradingSymbol>ABII</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001364846</rptOwnerCik>
            <rptOwnerName>Wendel Bruce</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ABRAXIS BIOSCIENCE LLC</rptOwnerStreet1>
            <rptOwnerStreet2>11755 WILSHIRE BOULEVARD, SUITE 2000</rptOwnerStreet2>
            <rptOwnerCity>LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90025</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Exec. VP Corporate Development</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2010-01-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>239</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>41.17</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3603</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Amount reported includes shares subject to unvested Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of ABII Common Stock. The reporting person is now reporting restricted stock units in Table I, rather than Table II. Accordingly, the number of shares beneficially owned on  Table I includes shares subject to vesting of Restricted Stock Units as set forth in footnotes 2 and 3.</footnote>
        <footnote id="F2">(i) The grant to the reporting person of 3,678 restricted stock units on November 5, 2008, of which 920 units vested on March 1, 2009. Of such vested units, 591 units were previously timely reported as paid out in common stock and 329 units were previously timely reported as withheld to satisfy the tax withholding obligations related to such vested units. As of the date of this filing, 2,758 shares beneficially owned pursuant to this grant remain subject to vesting; and (see next footnote)</footnote>
        <footnote id="F3">(ii) The grant to the reporting person of 1,446 restricted stock units on February 3, 2009, of which 362 units vested on February 3, 2009. Of such vested units, 206 units were previously timely reported as paid out in common stock and 156 units were previously timely reported as withheld to satisfy the tax withholding obligations related to such vested units. The current transaction reports  239 units withheld to satisfy the tax withholding obligations related to 542 units which vested on January 15, 2010, of which 303 shares were paid out in common stock. As of the date of this filing, 542 shares beneficially owned pursuant to this grant remain subject to vesting.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Bruce Wendel</signatureName>
        <signatureDate>2010-01-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
